Humacyte Presents New Immunogenicity Data on Human Acellular Vessels™ (HAVs™)
-- Data indicate HAV does not stimulate increase in panel reactive antibodies, an adaptive immune response correlated with increased risk...
Day: June 8, 2022
Apexigen Appoints William Duke as Chief Financial Officer
SAN CARLOS, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. (“Apexigen”), a clinical-stage company focused on developing innovative antibody-based...
Advaxis Reports Second Quarter Ended April 30, 2022 Financial Results and Provides a Business Update
Announced Publication of ADXS-PSA Data in The Oncologist Presented Updated Clinical and Immunogenicity Data from Ongoing Phase 1/2 Trial of...
AGTC Announces Key Appointments to Leadership Team
AGTC Welcomes Eduardo Jacobo as the Sr. Vice President of GMP Manufacturing and Dr. David Jacobs as the Sr. Vice...
Noah Medical to Showcase the Galaxy System™ at AABIP Annual Meeting
Next generation, fully integrated solution for navigated bronchoscopy received rave reviews at ATS 2022 in San FranciscoSAN CARLOS, Calif., June...
CymaBay Therapeutics Announces Presentations During The International Liver Congress™ 2022
NEWARK, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing...
IN8bio Announces Presentation at Jefferies Global Healthcare Conference and Additional June Investor and Scientific Conferences
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery...
Radius Health Expands Non-US Market Footprint for TYMLOS
Globalization has been a key priority for the Company over the past two yearsThree additional market agreements now signed and...
Ocuphire to Present New Interim Masked Safety Data for Oral APX3330 in Diabetics at Annual Macula Society Meeting
Of 103 Diabetic Subjects Enrolled in the 24-week ZETA-1 Phase 2b Trial, 70% Have Completed 12 or More Weeks Topline...
Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B Data Accepted for Presentation at the International Liver Congress™ 2022
SAN FRANCISCO, June 08, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that three abstracts highlighting data...
Intellia Therapeutics to Present Updated Interim Clinical Data from Ongoing Phase 1 Study of NTLA-2001 for the Treatment of Transthyretin (ATTR) Amyloidosis at the International Liver Congress™ 2022
Oral presentation to include additional durability data from patients treated with NTLA-2001, the first-ever systemically administered in vivo CRISPR investigational...
BBS-Bioactive Bone Substitutes Plc’s rights issue raised gross proceeds of EUR 3.5 million
BBS-Bioactive Bone Substitutes Plc, Company Announcement, Insider information, 8 June 2022 2.30 p.m. (CEST) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN...
Passage Bio Receives FDA Clearance of IND Application for PBML04 for Treatment of Metachromatic Leukodystrophy
• PBML04 represents the company’s fourth program to receive IND clearance PHILADELPHIA, June 08, 2022 (GLOBE NEWSWIRE) -- Passage Bio,...
iSpecimen Appoints Evan Cox as Vice President of Product Management
Industry Veteran Brings Nearly Two Decades of Experience in Healthcare Product Management to the CompanyLEXINGTON, Mass., June 08, 2022 (GLOBE...
Crinetics Presents Clinical and Research Results at ENDO 2022
CRN04894 Selected for Oral PresentationSAN DIEGO, June 08, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) announced that results...
Nacuity Pharmaceuticals Strengthens Scientific Advisory Board with Appointment of Nancy Holekamp, M.D., and Richard L. Lindstrom, M.D.
Internationally recognized experts bring robust clinical expertise to guide Nacuity as it advances two lead programs for the treatment of...
Cognition Therapeutics Announces Presentation at the Upcoming JMP Securities Life Sciences Conference
PURCHASE, N.Y., June 08, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX) announced that the company will participate in...
CBD of Denver Subsidiary Mellow Signs Agreement with Australian CBD and Hemp Wellness Brand
Denver, Colorado--(Newsfile Corp. - June 8, 2022) - CBD of Denver, Inc. (OTC Pink: CBDD), a cannabis roll-up company and...
Halberd Corp. and Mississippi State University Discuss Animal Testing as Prelude to FDA Certification
Jackson Center, Pennsylvania--(Newsfile Corp. - June 8, 2022) - Halberd Corporation (OTC Pink: HALB) and Mississippi State University (MSU) executed...
Over 100M Procedures Performed with Nanosonics’ trophon Devices Across North America Since 2011 Protecting Patients from Ultrasound Probe Cross-Contamination
Company Celebrates Over 25,000 installed trophon devices milestone INDIANAPOLIS--(BUSINESS WIRE)--Nanosonics (ASX: NAN), a leader in infection prevention solutions, today announced...